NASDAQ, MNTA - Momenta Pharma
Momenta is a biotechnology company with a product pipeline of both novel and
complex generic drugs. This pipeline is derived from our proprietary, innovative
technology platform for the detailed structural analysis of complex mixture
drugs. We use this platform to study the structure (thorough characterization of
chemical components), structure-process (design and control of manufacturing
process), and structure-activity (relating structure to biological and clinical
activity) of complex mixture drugs. The development product candidates and
research programs from our generic and novel portfolios are outlined below. ...
Read SEC Filing on NASDAQ.com »